ROS/K-ras调控Bmi1磷酸化促进化疗诱生胰腺癌干细胞的机制研究

81372665
2013
H1821.肿瘤治疗抵抗
殷涛
面上项目
教授
华中科技大学
70万元
化疗;胰腺癌干细胞;C11_胰肿瘤;活性氧
2014-01-01到2017-12-31
  • 中英文摘要
  • 结题摘要
  • 结题报告
  • 项目成果
  • 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
重置
序号 标题 类型 作者
1 Gemcitabine treatment promotes pancreatic cancer sternness through the Nox/ROS/NF-kappa B/STAT3 signaling cascade 期刊论文 Zhang Zhengle;Duan Qingke;Zhao Hengqiang;Liu Tao;Wu Heshui;Shen Qiang;Wang Chunyou;Yin Tao
2 Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells 期刊论文 Zhao Hengqiang;Duan Qingke;Zhang Zhengle;Li Hehe;Wu Heshui;Shen Qiang;Wang Chunyou;Yin Tao
3 Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine 期刊论文 Yin Tao;Zhang Zhengle;Cao Bin;Duan Qingke;Shi Pengfei;Zhao Hengqiang;Camara Soriba Naby;Shen Qiang;Wang Chunyou
4 Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry 期刊论文 Duan Qingke;Zhao Hengqiang;Zhang Zhengle;Li Hehe;Wu Heshui;Shen Qiang;Wang Chunyou;Yin Tao
查看更多信息请先登录或注册